Mobix Labs (NASDAQ: MOBX) registers 2.4M Class A shares in supplement

Rhea-AI Filing Summary

Mobix Labs, Inc. files a prospectus supplement registering up to 2,412,711 shares of Class A common stock. The supplement updates the prospectus with information from Current Reports on Form 8-K filed April 3, 2026 and April 9, 2026. The company’s Class A shares trade on Nasdaq under the symbol MOBX; the closing price was $3.04 on April 8, 2026.

Key Figures

Registered shares: 2,412,711 shares Closing price: $3.04 Registration statement: No. 333-290247

3 metrics

Registered shares 2,412,711 shares Up to 2,412,711 shares of Class A common stock registered by prospectus supplement

Closing price $3.04 Closing price of Class A common stock on April 8, 2026

Registration statement No. 333-290247 Registration Statement on Form S-1 (as amended)

Key Terms

Prospectus Supplement, Registration Statement on Form S-1, Rule 424(c)

3 terms

Prospectus Supplement regulatory

"This prospectus supplement amends the prospectus dated March 12, 2026"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Registration Statement on Form S-1 regulatory

"which forms a part of the Company’s Registration Statement on Form S-1, as amended (No. 333-290247)"

A registration statement on Form S-1 is a detailed filing a company submits to the U.S. securities regulator to register new shares for public sale; it includes a plain-language prospectus, financial statements, business description and risk factors. For investors it matters because it provides the official, comprehensive blueprint of the offering — like an owner’s manual — allowing buyers to assess risks, inspect financial health and compare valuation before deciding to invest.

Rule 424(c) regulatory

"and Rule 424(c) Registration Statement No. 333-290247 April 9, 2026"

Offering Details

primary

Offering

Offering Type primary

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Filed Pursuant to Rule 424(b)(3) and Rule 424(c)

Registration Statement No. 333-290247

April 9, 2026

PROSPECTUS SUPPLEMENT NO. 2

 

MOBIX LABS, INC.

Up to 2,412,711 SHARES OF CLASS A COMMON STOCK

This prospectus supplement amends the prospectus dated March 12, 2026 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the Company’s Registration Statement on Form S-1, as amended (No. 333-290247). This prospectus supplement is being filed to update and supplement the information included or incorporated by reference in the Prospectus with the information contained in the Current Report on Forms 8-K filed with the Securities and Exchange Commission (the “SEC”) on April 3, 2026 and April 9, 2026, as set forth below. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement.

Shares of our Class A Common Stock are listed on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “MOBX”. On April 8, 2026, the closing price of our Class A Common Stock was $3.04.

Investing in the Company’s Class A Common Stock involves risks. See “Risk Factors” beginning on page 5 of the Prospectus and under similar headings in any amendments or supplements to the Prospectus.

Neither the SEC nor any other regulatory body has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

The date of this Prospectus Supplement No. 2 is April 9, 2026

FAQ

What does Mobix Labs' prospectus supplement register (MOBX)?

The supplement registers up to 2,412,711 shares of Class A common stock. It amends the March 12, 2026 prospectus and incorporates information from Forms 8-K filed April 3 and April 9, 2026.

Will Mobix Labs receive proceeds from the registered shares (MOBX)?

The supplement does not state proceeds or allocation specifics. The prospectus context indicates an offering under the company’s registration statement; detailed use of proceeds is not provided in the excerpt.

What ticker and market data are included for MOBX?

Mobix Labs’ Class A common stock is listed on Nasdaq under MOBX. The supplement reports a closing price of $3.04 on April 8, 2026, as a point of market context.

What filings does this prospectus supplement rely on (MOBX)?

The supplement updates the prospectus with information contained in Current Reports on Form 8-K filed on April 3, 2026 and April 9, 2026, and should be read with the March 12, 2026 prospectus.